Feb 05, 2025
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.15 to $15.21.
The split itself did not change the total investment value.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) operates in the Pharmaceuticals: major industry.
Tonix Pharmaceuticals Holding Corp. company overviewTonix Pharmaceuticals Holding Corp.'s most recent stock split was on February 5, 2025. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has split its stock 8 times: a 1-for-20 reverse split on May 3, 2013, a 1-for-10 reverse split on March 17, 2017, a 1-for-10 reverse split on November 28, 2018, a 1-for-10 reverse split on November 1, 2019, a 1-for-32 reverse split on May 17, 2022, a 4-for-25 reverse split on May 10, 2023, a 1-for-32 reverse split on June 10, 2024, and a 1-for-100 reverse split on February 5, 2025.
Tonix Pharmaceuticals Holding Corp. has split its stock 8 times. This history records 8 reverse splits between May 3, 2013 and February 5, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Tonix Pharmaceuticals Holding Corp.'s 1-for-100 reverse split on February 5, 2025, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Tonix Pharmaceuticals Holding Corp. has not announced a new split in our records. Its most recent split was on February 5, 2025, 1 year ago. Companies announce splits in advance, and any new NASDAQ:TNXP split will appear on this page.